See all information on COVID-19, situation updates, risk assessments, questions and answers, latest evidence, surveillance and laboratory guidance and how to protect yourself and others.
In 2022, 3 967 confirmed cases of invasive Haemophilus influenzae disease were reported in the EU/EEA, representing a significant increase compared to the previous two years.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 6–12 July 2024 and includes updates on imported Oropouche human infections, Seasonal surveillance of West Nile virus infections, Locally acquired dengue, Yersinia enterocolitica, Cholera, Overview of respiratory virus epidemiology in the EU/EEA, Influenza A(H5N1), Mass gathering monitoring, Mpox and Middle Eastern Respiratory Syndrome (MERS).
This report presents pooled COVID-19 vaccine effectiveness (VE) estimates for the first, second and third booster doses (compared to complete primary vaccination with no booster) against hospitalisation due to COVID-19 and COVID-19-related death in resident populations ≥50 years of age living in the community.
This report collects all COVID-19 long-term care facilities (LTCF) data reported to ECDC from 2021 and concludes the EU/EEA LTCF COVID-19 specific surveillance data collection from 2021-2023.